References
- Vella-Brincat JWA Begg EJ Jensen BP et al. The pharmacokinetics and pharmacogenetics of the antiemetic cyclizine in palliative care patients. J. Pain Symptom Manage.43 (3), 540–548 (2012).
- Monene LM Goosen C Breytenbach JC Hadgraft J du Plessis J . Percutaneous absorption of cyclizine and its alkyl analogues. Eur. J. Pharm. Sci.24, 239–244 (2005).
- AHFS Drug Information 92 . McEvoyGK ( Ed.). American Society of Hospital Pharmacists, Bethesda, MD, USA, 1657–1658 (1992).
- Medicines.org.uk . Cyclizine Hydrochloride 50 mg Tablets-Summary of Product Characteristics (SPC) - (eMC). (Amdipharm Mercury Company Limited). (2016) www.medicines.org.uk/emc/medicine/27036.
- Jensen BP Ann Vella-Brincat JW Begg EJ . Quantification of cyclizine and norcyclizine in human plasma by liquid chromatography–tandem mass spectrometry (LC–MS/MS). J. Chromatogr. B879, 605–609 (2011).
- Ganjali MR Larijani B Faridbod F Norouzi P . Potentiometric Determination of Cyclizine by a PVC membrane Sensor. Int. J. Electrochem. Sci.8, 10487–10497 (2013).
- William HS Niteesh KC Joshua NL Troyen AB . The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money. Health Aff.30 (7), 1351–1357 (2011).
- Berndt ER Mortimer R Bhattacharjya A Parece A Tuttle E . Authorized generic drugs, price competition, and consumers’ welfare. Health Aff.26 (3), 790–9 (2007).
- Vella-Brincat JWA Begg EJ et al. The pharmacokinetics and pharmacogenetics of the antiemetic cyclizine in palliative care patients. J. Pain Symptom Manage.43 (3), 540–548 (2012).
- Walker RB Kanfer I . Pharmacokinetics of cyclizine following intravenous administration to human volunteers. Eur. J. Pharm. Sci.4, 301–306 (1996).
- World Medical Association . Declaration of Helsinki; Ethical Principles for Medical Research Involving Human Subjects. 59th World Medical Association General Assembly, Seoul, South Korea (2008). www.wma.net/en/30publications/10policies/b3/17c.pdf.
- The European Agency for the Evaluation of Medicinal Products, Evaluation of Medicines for Human Use. Note for guidance on the investigation of bioavailability and bioequivalence, 2001. www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003519.pdf.
- Pieter D Arnold V Steven S . Societal value of generic medicines beyond cost-saving through reduced prices. Expert Rev. Pharmacoecon. Outcomes Res.15 (4), 701–711 (2015).